Technical Analysis for KITE - Kite Pharma, Inc.

Grade Last Price % Change Price Change
grade A 179.3 -0.04% -0.08
KITE closed down 0.04 percent on Friday, September 22, 2017, on 79 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Extremely Strong Up Up Flat
See historical KITE trend table...

Date Alert Name Type % Chg
Aug 25 NR7 Range Contraction 28.90%
Aug 24 New 52 Week High Other 27.95%
Aug 24 New 52 Week Closing High Bullish 27.95%
Aug 24 Upper Bollinger Band Walk Other 27.95%
Aug 23 New 52 Week High Other 29.77%

Older signals for KITE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Kite Pharma, Inc. operates a clinical-stage biopharmaceutical company which focuses on the development and commercialization of novel cancer immunotherapy products. The company is developing a pipeline of eACT-based product candidates for the treatment of solid and hematological malignancies. Its lead product candidate includes KTE-C19, a chimeric antigen receptors-based engineered autologous cell therapy for the treatment of patients with relapsed/refractory diffuse large B cell lymphoma. The company is also developing T cell receptors-based therapies, which targets SSX2, NY-ESO-1, and MAGE antigens in various cancers. The company has collaboration agreement with the Surgery Branch of the National Cancer Institute. Kite Pharma, Inc. was founded in 2009 and is headquartered in Santa Monica, California.
Is KITE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 179.79
52 Week Low 39.82
Average Volume 2,279,390
200-Day Moving Average 88.3231
50-Day Moving Average 140.943
20-Day Moving Average 176.631
10-Day Moving Average 179.075
Average True Range 2.3372
ADX 81.76
+DI 52.58
-DI: 3.36
Chandelier Exit (Long, 3 ATRs) 172.7784
Chandelier Exit (Short, 3 ATRs) 141.0116
Upper Bollinger Band 193.8883
Lower Bollinger Band 159.3737
Percent B (%b) 0.58
Bandwidth 0.195405
MACD Line 11.2529
MACD Signal Line 13.3715
MACD Histogram -2.1185